Firma Nanion Technologies, Autor bei Presse-Blog

The SyncroPatch 384 is installed at the FDA for cardiac safety pharmacology studies

10. März 202211. März 2022 Firma Nanion TechnologiesBiotechnikautomated patch clamp, cardiac safety, cardiac safety testing, electrophysiology, Food and Drug Administration, herg, Ion Channels, patch clamp, Pharmacology, SyncroPatch 384

Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (FDA) at their Silver Spring site in Maryland. The SyncroPatch 384 will be used for high throughput automated patch clamp experiments Mehr

Nanion Technologies and NEXEL partner to open a new reference demonstration laboratory in South Korea

17. April 2020 Firma Nanion TechnologiesBiotechnikbusiness partnership, cardiomyocytes, cell monitoring technology, electrophysiology, in vitro assays, pluripotent stem cells, stem cells

April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, announces the partnership with NEXEL Co., Ltd., specialists in the manufacturing of hiPSC-derived cells. Under the partnership NEXEL will provide demonstration infrastructure in Mehr

Nanion Technologies and Assay.Works partner to offer drug discovery services for membrane transporter targets

7. November 2019 Firma Nanion TechnologiesAllgemeinassay.works, drug discovery, membrane transporter, nanion, pumps, research, service, ssm-technology

Nanion Technologies, a leading provider of automated electrophysiology systems, today announced the partnership with Assay.Works, experts in assay development and High Throughput Screening (HTS), who will be providing SURFE²R 96SE assays “As-a-Service” for membrane transporter research. Membrane transport proteins, enabling Mehr

Nanion Technologies Announces the Winners of the SURFE²R Grant Award – a Platform for Membrane Transporter Research and Screening

31. Oktober 2019 Firma Nanion TechnologiesBiotechnikantibiotic transport, assay, cell, grant application, membrane transporter, nanion, nanobodies, project, research, slc, ssm, wall'

Transporter proteins are gaining increasing interest in academic science and as therapeutic targets. Nanion’s two platforms, SURFE²R N1 and SURFE²E 96SE facilitate functional assays of electrogenic transport to elucidate kinetics, pharmacology, and other parameters of membrane transport activity. Earlier this Mehr

Autor: Firma Nanion Technologies